title: C-reactive protein, stroke, and statins.
abstract: C-reactive protein (CRP) is an important indicator and player in inflammatory diseases such as stroke. It may be involved in the earliest stages of stroke. Monitoring the levels of CRP may help in the prevention and treatment of stroke. Statin drugs may be useful in lowering CRP levels and the incidence of stroke.
authors.affiliation: School of Nursing and Health Studies, Georgetown University, Washington, DC 20057, USA. angerioa@georgetown.edu
authors.forename: Allan D
authors.initials: AD
authors.lastname: Angerio
authors.forename: Matthew F
authors.initials: MF
authors.lastname: Bialko
authors.forename: Bradley M
authors.initials: BM
authors.lastname: White
mesh_terms: D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000187:drug effects / Q000502:physiology; D003422:Critical Care; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015994:Incidence; D007249:Inflammation; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein